Jakson kuvaus
Welcome to Episode #6 of NAF This Week!
Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community — from research and advocacy to programs, events, and more.
In this episode: This week, Andrew discusses recent FDA developments and what a new rare disease framework could mean for the Ataxia community. He highlights the importance of patient engagement, outside expertise, and a more predictable drug development process, along with opportunities for the community to learn more and get involved.
Links & Resources Mentioned:
🔗 Rare…
Sivusto: nafbx.podbean.com

